The Chilmark Research team shares what we'll be looking for at HIMSS23 What we’re researching and...
(Re)Introducing the Chilmark Podcast
On an all-new episode of ChilCast: Healthcare Tech Talks, the team dives into the salient issues facing health IT in our monthly roundtable.
Oracle’s Acquisition of Cerner – Best Thing that Could Have Happened?
As an industry titan, Cerner has had ups and downs in recent years. But after OCHC and new announcements by Oracle, the future appears brighter than ever.
MEDITECH in the Chrysalis
MEDITECH Live was a window into a company stagnant in some places and electric in others. Will a dazzling butterfly or a dull moth emerge?
Hope for Healthcare at HAS22
We take a deeper look at the back-and-revamped HASummit. Although numerous challenges face the company, Health Catalyst seems to be rising to the occasion.
HASummit’22: For Real, In-Person
Health Catalyst’s HAS had attendees excited to meet in person once more. How is the analytics powerhouse adapting in this ever-evolving, challenging market?
Pushing Hard: Epic’s UGM’22
This being the first full-on UGM since the pandemic (yes, there was a UGM last year, albeit thinly...
UGM’22: Perspective of a Newbie
Chilmark Research is publishing two perspectives of this year’s UGM. Elena provides a perspective...
Telehealth in C Minor
The ATA conference returned this month, amidst a tumultuous time for telehealth. How did it stack up in the hotly contested health conference space?